163 related articles for article (PubMed ID: 24664584)
1. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
[TBL] [Abstract][Full Text] [Related]
2. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
5. Involvement of NEDD9 in the invasion and migration of gastric cancer.
Feng J; Zhao J; Xie H; Yin Y; Luo G; Zhang J; Feng Y; Li Z
Tumour Biol; 2015 May; 36(5):3621-8. PubMed ID: 25577245
[TBL] [Abstract][Full Text] [Related]
6. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
Wang D; Xu MR; Wang T; Li T; Zhu Jw
J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
[TBL] [Abstract][Full Text] [Related]
7. Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma.
Lerotić I; Vuković P; Hrabar D; Misir Z; Kruljac I; Pavić T; Forgač J; Ćaćić P; Ulamec M
Bosn J Basic Med Sci; 2021 Oct; 21(5):542-548. PubMed ID: 33485292
[TBL] [Abstract][Full Text] [Related]
8. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
[TBL] [Abstract][Full Text] [Related]
9. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
10. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
[TBL] [Abstract][Full Text] [Related]
11. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
12. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
[TBL] [Abstract][Full Text] [Related]
13. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
[TBL] [Abstract][Full Text] [Related]
14. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
15. High expression of NEDD9 predicts adverse outcomes of colorectal cancer patients.
Li P; Zhou H; Zhu X; Ma G; Liu C; Lin B; Mao W
Int J Clin Exp Pathol; 2014; 7(5):2565-70. PubMed ID: 24966970
[TBL] [Abstract][Full Text] [Related]
16. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of NEDD9, E-cadherin and γ-catenin and their prognostic significance in pancreatic ductal adenocarcinoma (PDAC).
Radulović P; Krušlin B
Bosn J Basic Med Sci; 2018 Aug; 18(3):246-251. PubMed ID: 29924959
[TBL] [Abstract][Full Text] [Related]
18. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
20. Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.
Hong SA; Son MW; Cho J; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee MS
APMIS; 2017 Nov; 125(11):996-1006. PubMed ID: 28885730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
